Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

U.S. FDA removes safety warning from Smith & Nephew's diabetic gel

December 5, 2018 2:32 PM
93 0

(Reuters) - British medical products maker Smith & Nephew said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved the removal of a safety warning on its treatment for lower extremity diabetic neuropathic ulcers.

The label on the box of the Regranex gel since 2008 warned of “increased rate of mortality secondary to malignancy” after an initial study, the company said.

Read more

Share in social networks:

Comments - 0